TrialRespiratory research2019

Treatment response to indacaterol/glycopyrronium versus salmeterol/fluticasone in exacerbating COPD patients by gender: a post-hoc analysis in the FLAME study.

Jadwiga A Wedzicha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.